Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Feb 6;382(6):534-544.
doi: 10.1056/NEJMoa1905593.

Lower Versus Traditional Treatment Threshold for Neonatal Hypoglycemia

Collaborators, Affiliations
Randomized Controlled Trial

Lower Versus Traditional Treatment Threshold for Neonatal Hypoglycemia

Anne A M W van Kempen et al. N Engl J Med. .

Abstract

Background: Worldwide, many newborns who are preterm, small or large for gestational age, or born to mothers with diabetes are screened for hypoglycemia, with a goal of preventing brain injury. However, there is no consensus on a treatment threshold that is safe but also avoids overtreatment.

Methods: In a multicenter, randomized, noninferiority trial involving 689 otherwise healthy newborns born at 35 weeks of gestation or later and identified as being at risk for hypoglycemia, we compared two threshold values for treatment of asymptomatic moderate hypoglycemia. We sought to determine whether a management strategy that used a lower threshold (treatment administered at a glucose concentration of <36 mg per deciliter [2.0 mmol per liter]) would be noninferior to a traditional threshold (treatment at a glucose concentration of <47 mg per deciliter [2.6 mmol per liter]) with respect to psychomotor development at 18 months, assessed with the Bayley Scales of Infant and Toddler Development, third edition, Dutch version (Bayley-III-NL; scores range from 50 to 150 [mean {±SD}, 100±15]), with higher scores indicating more advanced development and 7.5 points (one half the SD) representing a clinically important difference). The lower threshold would be considered noninferior if scores were less than 7.5 points lower than scores in the traditional-threshold group.

Results: Bayley-III-NL scores were assessed in 287 of the 348 children (82.5%) in the lower-threshold group and in 295 of the 341 children (86.5%) in the traditional-threshold group. Cognitive and motor outcome scores were similar in the two groups (mean scores [±SE], 102.9±0.7 [cognitive] and 104.6±0.7 [motor] in the lower-threshold group and 102.2±0.7 [cognitive] and 104.9±0.7 [motor] in the traditional-threshold group). The prespecified inferiority limit was not crossed. The mean glucose concentration was 57±0.4 mg per deciliter (3.2±0.02 mmol per liter) in the lower-threshold group and 61±0.5 mg per deciliter (3.4±0.03 mmol per liter) in the traditional-threshold group. Fewer and less severe hypoglycemic episodes occurred in the traditional-threshold group, but that group had more invasive diagnostic and treatment interventions. Serious adverse events in the lower-threshold group included convulsions (during normoglycemia) in one newborn and one death.

Conclusions: In otherwise healthy newborns with asymptomatic moderate hypoglycemia, a lower glucose treatment threshold (36 mg per deciliter) was noninferior to a traditional threshold (47 mg per deciliter) with regard to psychomotor development at 18 months. (Funded by the Netherlands Organization for Health Research and Development; HypoEXIT Current Controlled Trials number, ISRCTN79705768.).

Similar articles

  • Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years.
    McKinlay CJ, Alsweiler JM, Ansell JM, Anstice NS, Chase JG, Gamble GD, Harris DL, Jacobs RJ, Jiang Y, Paudel N, Signal M, Thompson B, Wouldes TA, Yu TY, Harding JE; CHYLD Study Group. McKinlay CJ, et al. N Engl J Med. 2015 Oct 15;373(16):1507-18. doi: 10.1056/NEJMoa1504909. N Engl J Med. 2015. PMID: 26465984 Free PMC article.
  • Threshold-based insulin-pump interruption for reduction of hypoglycemia.
    Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group. Bergenstal RM, et al. N Engl J Med. 2013 Jul 18;369(3):224-32. doi: 10.1056/NEJMoa1303576. Epub 2013 Jun 22. N Engl J Med. 2013. PMID: 23789889 Clinical Trial.
  • Tight Glycemic Control in Critically Ill Children.
    Agus MS, Wypij D, Hirshberg EL, Srinivasan V, Faustino EV, Luckett PM, Alexander JL, Asaro LA, Curley MA, Steil GM, Nadkarni VM; HALF-PINT Study Investigators and the PALISI Network. Agus MS, et al. N Engl J Med. 2017 Feb 23;376(8):729-741. doi: 10.1056/NEJMoa1612348. Epub 2017 Jan 24. N Engl J Med. 2017. PMID: 28118549 Free PMC article. Clinical Trial.
  • Hypoglycemia in the Newborn.
    Rozance PJ, Wolfsdorf JI. Rozance PJ, et al. Pediatr Clin North Am. 2019 Apr;66(2):333-342. doi: 10.1016/j.pcl.2018.12.004. Epub 2019 Feb 1. Pediatr Clin North Am. 2019. PMID: 30819340 Review.
  • Neonatal Hypoglycemia: A Continuing Debate in Definition and Management.
    Stomnaroska-Damcevski O, Petkovska E, Jancevska S, Danilovski D. Stomnaroska-Damcevski O, et al. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(3):91-7. doi: 10.1515/prilozi-2015-0083. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015. PMID: 27442401 Review.
See all similar articles

MeSH terms

Associated data

Feedback